Skip to main content

Digital Health Market to 2027 – Global Analysis and Forecasts | CERNER, MCKESSON, AGFA-GEVAERT GROUP

Digital health has become popular in recent years with growing deployment of digital health platforms such as mobile health, telehealth, and other wireless solutions across hospitals and nursing homes so as to provide patients with real time healthcare services. The digital health has grown from robotics to transform surgical procedures and 3D printers printing human organs the path for digital health market expansion. Digital health industry is expected to become one of the most advanced healthcare sector in the future.
The market of digital health is anticipated to grow with a significant rate in the coming years, owing to the factors such as technological advancements in healthcare IT, favorable government regulations are driving the digital health market. Moreover, increasing venture capital funding including private equity and corporate venture capital in the health IT, growing security concerns for patient data will foster market growth opportunities in the digital health market.
The “Global Digital Health Market Analysis to 2027” is a specialized and in-depth study of the healthcare IT industry with a focus on the global digital health market trend. The report aims to provide an overview of global digital health market with detailed market segmentation by product, component, end-user and geography. The global digital health market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the digital health market.

Major Key Players of the Digital Health Market are: 
1. Cerner Corporation
2. McKesson Corporation
3. Agfa-Gevaert Group
4. Allscripts
5. Koninklijke Philips N.V.
6. Athenahealth, Inc.
7. Epic Systems Corporation
8. GE Healthcare
9. Alphabet Inc.
10. Siemens Healthineers
11. WellCare Health Plans
The global digital health market is segmented on the basis of product, component, and end-user. The product segment includes wearable devices, and healthcare information systems (HIS). The segment of wearable devices is further classified into, digital therapeutic devices and diagnostic & monitoring devices. On the digital therapeutic devices basis market is segmented as, respiratory therapy devices, pain management devices, insulin pumps devices, and rehabilitation devices. The segment of healthcare information systems (HIS) is further classified into, computerized physician order entry (CPOE), mHealth, clinical decision support system (CDSS), and EHR/EMR. Based on component, the digital health market is segmented as, services, hardware and software. Based on end user, the market is classified as B2B and B2C.
The digital health market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global digital health market based on product, component, and end-user. It also provides market size and forecast till 2027 for overall digital health market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The digital health market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to be the largest contributor in the overall revenue generation in digital health market, due to growing prevalence of chronic diseases along with increasing geriatric population, rising the use of electronic health data will boost market growth in the region. However, Asia-Pacific digital health market is expected to show lucrative growth during the forecast period, due to rapid implementation of telehealth & mobile health technology along with growing joint ventures for digital health solution in the region are factors further propelling the growth.
The digital health market report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Comments

Popular posts from this blog

Addiction Treatment Market 2025 Business Research Analysis by Key Vendors – Cipla , Allergan , Alkermes , Pfizer , Orexo

Addiction Treatment Market report provides in-depth statistics and analysis available on the market status of the Addiction Treatment Manufacturers and is a valuable method of obtaining guidance and direction for companies and business enterprise insider considering the Addiction Treatment market. It contains the analysis of drivers, challenges, and restraints impacting the industry. Addiction Treatment Market report also provide a thorough understanding of the cutting-edge competitive analysis of the emerging market trends along with the drivers, restraints, challenges, and opportunities in the Addiction Treatment Market to offer worthwhile insights and current scenario for making right decision. The report covers the prominent players in the market with detailed SWOT analysis, financial overview, and key developments of the products/services from the past three years. Moreover, the report also offers a 360º outlook of the market through the competitive landscape of the global ind...

Rheumatic Disorders Drugs Market to 2024 – Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry

The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion. The majority of rheumatic disorders are treated using largely genericized pain management drugs, and there are no cures for any of the key indications, leaving a large unmet need for better disease-modifying drugs to be developed. This report covers all rheumatic disorders, but there is a particular focus on five key diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus and psoriatic arthritis, as these conditions have the largest pipelines within the therapy area. Get Sample Report @   https://www.reportsweb.com/inquiry&RW00012429175/sample  The market size for rheumatic disorder therapeutics was $58.97 billion in 2017 and is expected to grow at...

Multiple Myeloma Therapeutics in Major Developed Markets to 2021-Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments

Multiple Myeloma (MM) is a hematological malignancy characterized by the proliferation of plasma cells in the bone marrow. It is the second-most frequently diagnosed hematological malignancy, with an annual prevalence in the US of about 45,000. The disease is considered incurable, although the past decade has seen significant improvements in therapy, driven by a greater understanding of pathophysiology. Many of the leading drugs in the market were approved over the past 10-15 years, and have improved median survival rates by about 50%. The MM pipeline contains 267 products in active development, encompassing a range of molecule types and therapeutic targets. The innovation that has characterized the market over recent years is also clearly present in the current pipeline, with a strong presence of novel, targeted products. Get Sample Report @   https://www.reportsweb.com/inquiry&RW0001170026/sample  Scope -The MM market landscape has undergone significan...